Risk Assessment

Rapsomaniki, E., Shah, A., Perel, P., Denaxas, S., George, J., Nicholas, O., et al. (2014). Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J, 35, 844-52. http://doi.org/10.1093/eurheartj/eht533
. Y. Sun, L., Zghebi, S. S., Eddeen, A. B., Liu, P. P., Lee, D. S., Tu, K., et al. (2022). Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes. Diabetes Care, 45, 2737-2745. http://doi.org/10.2337/dc22-0894
Rebordosa, C., Plana, E., Rubino, A., Aguado, J., Martinez, D., Lei, A., et al. (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715-1733. http://doi.org/10.2147/copd.s363997
Dziopa, K., Asselbergs, F. W., Gratton, J., Chaturvedi, N., & Schmidt, A. F. (2022). Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia, 65, 644-656. http://doi.org/10.1007/s00125-021-05640-y
Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., . Y. Strauss, V., et al. (2021). Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England. Bmj Open, 11, e046712. http://doi.org/10.1136/bmjopen-2020-046712
Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., . Y. Strauss, V., et al. (2021). Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England. Bmj Open, 11, e046712. http://doi.org/10.1136/bmjopen-2020-046712